124 related articles for article (PubMed ID: 8935476)
1. Homocysteine and cardiovascular disease.
Scott J; Weir D
QJM; 1996 Aug; 89(8):561-3. PubMed ID: 8935476
[No Abstract] [Full Text] [Related]
2. Elevated total plasma homocysteine and 677C-->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease.
de Franchis R; Mancini FP; D'Angelo A; Sebastio G; Fermo I; de Stefano V; Margaglione M; Mazzola G; di Minno G; Andria G
Am J Hum Genet; 1996 Jul; 59(1):262-4. PubMed ID: 8659535
[No Abstract] [Full Text] [Related]
3. The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's disease.
Harmon DL; Ramsbottom D; Whitehead AS; Ben-Shlomo Y; Davey-Smith G
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):671. PubMed ID: 9219765
[No Abstract] [Full Text] [Related]
4. Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke.
Soriente L; Coppola A; Madonna P; Cerbone AM; Di Minno G; Orefice G; D'Angelo A
Stroke; 1998 Apr; 29(4):869-71. PubMed ID: 9550528
[No Abstract] [Full Text] [Related]
5. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide--a cautionary tale.
Erbe RW; Salis RJ
N Engl J Med; 2003 Jul; 349(1):5-6. PubMed ID: 12840086
[No Abstract] [Full Text] [Related]
6. Folate and coronary heart disease.
Verhoef P; Stampfer MJ; Rimm EB
Curr Opin Lipidol; 1998 Feb; 9(1):17-22. PubMed ID: 9502330
[TBL] [Abstract][Full Text] [Related]
7. Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.
Blom HJ
Eur J Pediatr; 1998 Apr; 157 Suppl 2():S131-4. PubMed ID: 9587041
[TBL] [Abstract][Full Text] [Related]
8. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia.
Harmon DL; Woodside JV; Yarnell JW; McMaster D; Young IS; McCrum EE; Gey KF; Whitehead AS; Evans AE
QJM; 1996 Aug; 89(8):571-7. PubMed ID: 8935478
[TBL] [Abstract][Full Text] [Related]
9. Future for folates in cardiovascular disease.
Verhaar MC; Rabelink TJ
Eur J Clin Invest; 1999 Aug; 29(8):657-8. PubMed ID: 10457147
[No Abstract] [Full Text] [Related]
10. Mutated 5,10-methylenetetrahydrofolate reductase, hyperhomocysteinemia and risk for cardiovascular disease. Nature, nurture or nonsense?
Blom HJ
Eur J Clin Invest; 2001 Jan; 31(1):6-8. PubMed ID: 11168432
[No Abstract] [Full Text] [Related]
11. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.
Chango A; Potier De Courcy G; Boisson F; Guilland JC; Barbé F; Perrin MO; Christidès JP; Rabhi K; Pfister M; Galan P; Hercberg S; Nicolas JP
Br J Nutr; 2000 Dec; 84(6):891-6. PubMed ID: 11177206
[TBL] [Abstract][Full Text] [Related]
12. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency.
Selzer RR; Rosenblatt DS; Laxova R; Hogan K
N Engl J Med; 2003 Jul; 349(1):45-50. PubMed ID: 12840091
[No Abstract] [Full Text] [Related]
13. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.
Vychytil A; Födinger M; Wölfl G; Enzenberger B; Auinger M; Prischl F; Buxbaum M; Wiesholzer M; Mannhalter C; Hörl WH; Sunder-Plassmann G
Kidney Int; 1998 Jun; 53(6):1775-82. PubMed ID: 9607212
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
Ueland PM; Clarke R
Clin Chem; 2007 May; 53(5):807-9. PubMed ID: 17468406
[No Abstract] [Full Text] [Related]
15. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida.
Bjørke-Monsen AL; Ueland PM; Schneede J; Vollset SE; Refsum H
QJM; 1997 Sep; 90(9):593-6. PubMed ID: 9349452
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
Carlsson CM
Drugs Aging; 2006; 23(6):491-502. PubMed ID: 16872232
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
[TBL] [Abstract][Full Text] [Related]
19. Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction.
Shiran A; Remer E; Asmer I; Karkabi B; Zittan E; Cassel A; Barak M; Rozenberg O; Karkabi K; Flugelman MY
Isr Med Assoc J; 2015 May; 17(5):288-92. PubMed ID: 26137654
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine metabolism in renal failure.
van Guldener C; Stam F; Stehouwer CD
Kidney Int Suppl; 2001 Feb; 78():S234-7. PubMed ID: 11169017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
